OrphanPacific
Manufacturing · Japan · 51-200 Employees
View Company Info for Free
Overview
Headquarters
中之島セントラルタワー 2-2-7 中之島 7階, 大阪市北区, 大阪府, 53...Phone Number
+61 367798151Website
www.orphanpacific.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1
About OrphanPacific
OrphanPacific, Inc. specializes in developing treatments for rare diseases, focusing on patients who are eagerly awaiting effective therapies. The company provides comprehensive information and support for both patients and healthcare professionals regarding rare diseases and orphan drugs. Their innovative pharmaceutical model emphasizes collaboration with patients to address the challenges associated with rare conditions. OrphanPacific is committed to raising awareness and improving access to treatments for these underserved patient populations.Explore more
OrphanPacific Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is OrphanPacific your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on OrphanPacific recently announced quarterly report
Check if OrphanPacific has recently received funding, and reach out quickly before it becomes old news!
Check out if OrphanPacific is spiking on competitors!
Product Launch: Get notified when OrphanPacific launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if OrphanPacific had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at OrphanPacific
Funding: Get notified immidiatlly once OrphanPacific has new funding data
OrphanPacific, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Company Profile Activity
Activity Insights
OrphanPacific is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
OrphanPacific is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about OrphanPacific.
OrphanPacific Tech Stack
A closer look at the technologies used by OrphanPacific
OrphanPacific News & Media
BioCryst Announces Approval of ORLADEYO™ (berotralstat) in Japan for the Prophylactic Treatment of Hereditary Angioedema
RESEARCH TRIANGLE PARK, N.C., Jan. 22, 2021 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the Ministry of Health, Labor and Welfare (MHLW) in Japan has granted marketing and manufacturing approval for oral, once-daily ORLADEYO™ (berotralstat) 150 mg for prophylactic treatment of hereditary angioedema (HAE) in adults and pediatric patients 12 years and older.
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding OrphanPacific
Sign Up For FreeTo access detailed company insights
OrphanPacific, Inc. specializes in developing treatments for rare diseases, focusing on patients who are eagerly awaiting effective therapies. The company provides comprehensive information and support for both patients and healthcare professionals regarding rare diseases and orphan drugs. Their innovative pharmaceutical model emphasizes collaborat... Read More
